APA

Viglietta V., Shi F., Hu Q., Ren Y., Keilty J., Wolff H., McCarthy R., Kropp J., Weber P. & Soglia J. (20210902). Phase 1 study to evaluate safety, tolerability and pharmacokinetics of a novel intra-tympanic administered thiosulfate to prevent cisplatin-induced hearing loss in cancer patients. : Investigational new drugs.

Chicago

Viglietta Vissia, Shi Fuxin, Hu Qi-Ying, Ren Yong, Keilty John, Wolff Heather, McCarthy Ryan, Kropp Jason, Weber Pete and Soglia John. 20210902. Phase 1 study to evaluate safety, tolerability and pharmacokinetics of a novel intra-tympanic administered thiosulfate to prevent cisplatin-induced hearing loss in cancer patients. : Investigational new drugs.

Harvard

Viglietta V., Shi F., Hu Q., Ren Y., Keilty J., Wolff H., McCarthy R., Kropp J., Weber P. and Soglia J. (20210902). Phase 1 study to evaluate safety, tolerability and pharmacokinetics of a novel intra-tympanic administered thiosulfate to prevent cisplatin-induced hearing loss in cancer patients. : Investigational new drugs.

MLA

Viglietta Vissia, Shi Fuxin, Hu Qi-Ying, Ren Yong, Keilty John, Wolff Heather, McCarthy Ryan, Kropp Jason, Weber Pete and Soglia John. Phase 1 study to evaluate safety, tolerability and pharmacokinetics of a novel intra-tympanic administered thiosulfate to prevent cisplatin-induced hearing loss in cancer patients. : Investigational new drugs. 20210902.